Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis

Rona Therapeutics, Inc and Keymed Biosciences, announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis.